Asia-Pacific Pharmaceutical Solvent Market, By Product (Alcohol, Amine, Esters, Ethers, Aromatic Hydrocarbons, Chlorinated Solvents, Ketones, and Others), Application (Pharmaceutical, Research Laboratories, Chemical, and Others), Geography (China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights: Asia-Pacific Pharmaceutical Solvent Market
Asia-Pacific pharmaceutical solvent market is expected to grow in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing with a CAGR of 5.4% in the forecast period of 2021 to 2028 and is expected to reach USD 3,141,252.32 thousand by 2028. Growing pharmaceutical and healthcare sectors across the globe are expected to drive the Asia-Pacific pharmaceutical solvent market growth.
Pharmaceutical solvents refer to chemical compounds, which are majorly utilized in the manufacturing of drugs in the pharmaceutical industry. These solvents are used in dissolving other products and components finding its usage as a manufacturing block by providing the molecules required in the production of drugs and pharmaceuticals. These solvents are also utilized in the extraction and purification process. Most of the pharmaceutical solvents cannot be removed completely from the final drugs. It is, however, desired that a pharmaceutical solvent should not change properties of either of the chemicals involved in the reaction.
These alcoholic solvents are utilized in numerous major pharmaceutical drugs such as glycol, isopropanol, and ethanol and growth of pharmaceutical and healthcare sector are the major factors driving the market growth. Furthermore, high production costs and complex manufacturing process act as a restraint for the growth of the market. On the other hand, growing research and development activities and development of new drug manufacturing methods and technologies act as an opportunity for the market. However, rise in concerns regarding the toxicity of solvents might further create challenges for the market growth.
Asia-Pacific pharmaceutical solvent market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Asia-Pacific Pharmaceutical Solvent market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Get Exclusive Sample Copy of this Report Here
Asia-Pacific Pharmaceutical Solvent Market Scope and Market Size
The Asia-Pacific pharmaceutical solvent market is segmented into two notable segments which are based on product and application. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the Asia-Pacific pharmaceutical solvent market is segmented into alcohol, amine, esters, ethers, aromatic hydrocarbons, chlorinated solvents, ketones, and others. In 2021, the alcohol segment is expected to dominate the market owing to the extensive use of alcoholic solvents as a direct solvent in pharmaceuticals and growing usage of alcoholic solvents in OTC drugs.
- On the basis of application, the Asia-Pacific pharmaceutical solvent market is segmented into pharmaceutical, research laboratories, chemicals, and others. In 2021, the pharmaceutical segment is expected to dominate the market owing to the growing pharmaceutical and healthcare industries in the region.
Asia-Pacific Pharmaceutical Solvent Market Country Level Analysis
Asia-Pacific pharmaceutical solvent market is analyzed, and market size information is provided by product and application as referenced above.
The countries covered in the Asia-Pacific pharmaceutical solvent market report are China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific. China is leading the growth of the Asia-Pacific market owing to rising demand for pharmaceutical industry & growing research & development activities.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Players to Enhance the Awareness for Pharmaceutical Solvent is Boosting Growth of Asia-Pacific Pharmaceutical Solvent Market
Asia-Pacific pharmaceutical solvent market also provides you with a detailed market analysis for every country's growth in a particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Asia-Pacific Pharmaceutical Solvent Market Share Analysis
Asia-Pacific pharmaceutical solvent market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, and technology lifeline curve. The above data points are only related to the companies’ focus on the Asia-Pacific pharmaceutical solvent market.
Some of the major players operating in the Asia-Pacific pharmaceutical solvent market are Dupont, BASF SE, Royal Dutch Shell Plc, Merck KGaA, Brenntag SE, Clariant AG, Dow, LyondellBasell Industries Holdings B.V., and Exxon Mobil Corporation among others.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and regional expansion of leading players in the region are also initiated by companies worldwide, which further accelerate the growth of the Asia-Pacific pharmaceutical solvent market.
For instance,
- In August 2021, BASF SE expanded its Verbund site in Nanjing, China. Production capacities are expected to be expanded for several downstream chemical plants. This expansion has helped the company to extend its solvent production capacity.
SKU-